IDH2 and acute myeloid leukemia: Furthermore, in our cohort we also found a slightly higher median age at diagnosis in patients with mutated IDH1 gene than in patients with wild type IDH1. Our cohort covered a wide age span including both younger and older patients, but future studies investigating the impact of IDH mutations specifically in older AML patients could be warranted.